Holen Sie sich die Stockscreener-App
3.20
9.60%
-0.34
Handel nachbörslich:
3.20
Polypid Ltd Aktie (PYPD) Neueste Nachrichten
PolyPid to Report Third Quarter 2024 Financial Results and Operational Highlights on November 13, 2024 - GlobeNewswire
Will PolyPid Wield The SHIELD? - RTTNews
Rosalind Advisors, Inc. Reduces Stake in PolyPid Ltd - GuruFocus.com
PolyPid Announces Publication in International Journal of - GlobeNewswire
PolyPid Announces Publication in International Journal of Surgery Highlighting Results of Phase 3 SHIELD I Trial of D-PLEX₁₀₀ in Prevention of Surgical Site Infections in Abdominal Colorectal Surgery - StockTitan
PolyPid retains stock target, buy rating on positive trial enrollment update By Investing.com - Investing.com South Africa
PolyPid retains stock target, buy rating on positive trial enrollment update - Investing.com India
PolyPid completes enrollment for phase 3 trial - Investing.com
PolyPid Nears Completion of Key Phase 3 Trial - TipRanks
PolyPid Announces Last Patient In for Planned Unblinded - GlobeNewswire
PolyPid Announces Last Patient In for Planned Unblinded Interim Analysis in the Ongoing SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections - StockTitan
PolyPid to Participate in Three Upcoming Fall Investor Conferences - GlobeNewswire
Equities Analysts Offer Predictions for PolyPid Ltd.’s Q3 2024 Earnings (NASDAQ:PYPD) - Defense World
HC Wainwright Reiterates “Buy” Rating for PolyPid (NASDAQ:PYPD) - Defense World
PolyPid Ltd. (NASDAQ:PYPD) Q2 2024 Earnings Call Transcript - Insider Monkey
Earnings call: PolyPid reports a net loss of $6.3 million in the second-quarter of 2024 - Investing.com
PolyPid Reports Growth in Mid-Year Assets - TipRanks
PolyPid Advances SHIELD II Trial with Solid Financing - TipRanks
PolyPid Provides Corporate Update and Reports Second Quarter 2024 Financial Results - GlobeNewswire
Analyzing Silk Road Medical (NASDAQ:SILK) & PolyPid (NASDAQ:PYPD) - Defense World
PolyPid (PYPD) Scheduled to Post Earnings on Wednesday - Defense World
PolyPid secures $14 million in private placement - Investing.com
PolyPid secures $14 million in private placement By Investing.com - Investing.com UK
PolyPid Secures Funding, Extends Runway for D-PLEX100 Trial - TipRanks
PolyPid Announces Private Placement for Up to $14 Million in Gross Proceeds - StockTitan
PolyPid to Report Second Quarter 2024 Financial Results and Operational Highlights on August 14, 2024 - GlobeNewswire
PolyPid stock hits 52-week low at $3.35 amid market challenges - Investing.com
PolyPid (NASDAQ:PYPD) Trading 1.7% Higher - Defense World
PolyPid Ends Equity Sales Agreement, No Penalties Incurred - TipRanks
PolyPid Revamps Share Option Plan for Stakeholders - TipRanks
Critical Comparison: PolyPid (NASDAQ:PYPD) versus GBS (NYSE:GBS) - Defense World
PolyPid Ltd. (NASDAQ:PYPD) Forecasted to Post Q2 2024 Earnings of ($1.51) Per Share - Defense World
PolyPid hosts KOL call, provides update on ongoing SHIELD II Phase 3 trialTipRanks.com - TipRanks
Superficial Punctate Keratitis Market Size 2032 | Market Drivers & Barriers, Clinical Trials and Latest Drugs - EIN News
PolyPid Advances Trial for Infection PreventionTipRanks.com - TipRanks
PolyPid Hosts KOL Call to Discuss Significant Unmet Medical Need in Surgical Site Infections Prevention and Provides ... - GlobeNewswire
PolyPid Hosts KOL Call to Discuss Significant Unmet Medical - GlobeNewswire
Comparing PolyPid (NASDAQ:PYPD) and Nemaura Medical (NASDAQ:NMRD) - Defense World
PolyPid to Host Virtual KOL Event on June 17, 2024, and Provide an Update on the Company's Ongoing D-PLEX₁₀₀ ... - GlobeNewswire
Wall Street Analysts Think PolyPid Ltd. (PYPD) Could Surge 289%: Read This Before Placing a Bet - Yahoo News UK
PolyPid Ltd. Schedules Shareholder MeetingTipRanks.com - TipRanks
PolyPid Enhances Share Option Plan to Motivate StaffTipRanks.com - TipRanks
Is Liquidia Technologies (LQDA) Outperforming Other Medical Stocks This Year? - Yahoo News UK
PolyPid (NASDAQ:PYPD) Earns Buy Rating from HC Wainwright - Defense World
How Much Of PolyPid Ltd. (NASDAQ:PYPD) Do Insiders Own? - Yahoo Lifestyle UK
PolyPid Ltd. (NASDAQ:PYPD) Q1 2024 Earnings Call Transcript - Insider Monkey
Earnings call: PolyPid reports progress in D-PLEX100 trial, eyes expansion - Investing.com
PolyPid Ltd (PYPD) Q1 2024 Earnings Call Transcript - Seeking Alpha
PolyPid Advances Phase 3 Trial, Strengthens FinancesTipRanks.com - TipRanks
1.11%
0.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):